Kappa-opioid receptor binding varies inversely with tumor grade in human gliomas.

Autor: Pan EC; E. A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University Health Sciences Center, Missouri 63110-0250, USA., Bohn LM, Belcheva MM, Thomas GE, Manepalli AN, Mamone JY, Johnson FE, Coscia CJ

Publikováno v: Cancer [Cancer] 1998 Dec 15; Vol. 83 (12), pp. 2561-6.

Sigma and opioid receptors in human brain tumors.

Autor: Thomas GE; Department of Biochemistry, St. Louis University School of Medicine, Missouri 63104., Szücs M, Mamone JY, Bem WT, Rush MD, Johnson FE, Coscia CJ

Publikováno v: Life sciences [Life Sci] 1990; Vol. 46 (18), pp. 1279-86.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer.

Autor: Zeng, C¹, Vangveravong, S¹, McDunn, J E², Hawkins, W G³, Mach, R H⁴

Publikováno v: British Journal of Cancer. 10/29/2013, Vol. 109 Issue 9, p2368-2377. 10p.

Sigma-2 ligands induce tumour cell death by multiple signalling pathways.

Autor: Zeng, C¹, Rothfuss, J¹, Zhang, J¹, Chu, W¹, Vangveravong, S¹, Tu, Z¹, Pan, F¹, Chang, K C², Hotchkiss, R², Mach, R H³

Publikováno v: British Journal of Cancer. 2/14/2012, Vol. 106 Issue 4, p693-701. 9p. 3 Black and White Photographs, 1 Chart, 3 Graphs.